These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32573957)

  • 1. Sarcoma and the 100,000 Genomes Project: our experience and changes to practice.
    Prendergast SC; Strobl AC; Cross W; Pillay N; Strauss SJ; Ye H; Lindsay D; Tirabosco R; Chalker J; Mahamdallie SS; Sosinsky A; ; ; Flanagan AM; Amary F
    J Pathol Clin Res; 2020 Oct; 6(4):297-307. PubMed ID: 32573957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
    Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
    Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing.
    Hensley ML; Chavan SS; Solit DB; Murali R; Soslow R; Chiang S; Jungbluth AA; Bandlamudi C; Srinivasan P; Tap WD; Rosenbaum E; Taylor BS; Donoghue MTA; Hyman DM
    Clin Cancer Res; 2020 Jul; 26(14):3881-3888. PubMed ID: 32299819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
    Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
    Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.
    Sullivan LM; Folpe AL; Pawel BR; Judkins AR; Biegel JA
    Mod Pathol; 2013 Mar; 26(3):385-92. PubMed ID: 23060122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary round cell sarcomas of the urinary bladder with EWSR1 rearrangement: a multi-institutional study of thirteen cases with a review of the literature.
    Baisakh MR; Tiwari A; Gandhi JS; Naik S; Sharma SK; Balzer BL; Sharma S; Peddinti K; Jha S; Sahu PK; Pradhan D; Geller M; Amin MB; Dhillon J; Mohanty SK
    Hum Pathol; 2020 Oct; 104():84-95. PubMed ID: 32798549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine.
    Vassy JL; Lautenbach DM; McLaughlin HM; Kong SW; Christensen KD; Krier J; Kohane IS; Feuerman LZ; Blumenthal-Barby J; Roberts JS; Lehmann LS; Ho CY; Ubel PA; MacRae CA; Seidman CE; Murray MF; McGuire AL; Rehm HL; Green RC;
    Trials; 2014 Mar; 15():85. PubMed ID: 24645908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
    Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
    Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
    Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
    J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
    Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
    Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group.
    Laetsch TW; Roy A; Xu L; Black JO; Coffin CM; Chi YY; Tian J; Spunt SL; Hawkins DS; Bridge JA; Parsons DW; Skapek SX
    Clin Cancer Res; 2018 Aug; 24(16):3888-3897. PubMed ID: 29691299
    [No Abstract]   [Full Text] [Related]  

  • 18. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
    van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
    PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
    Subhash VV; Huang L; Kamili A; Wong M; Chen D; Venn NC; Atkinson C; Mayoh C; Venkat P; Tyrrell V; Marshall GM; Cowley MJ; Ekert PG; Norris MD; Haber M; Henderson MJ; Sutton R; Fletcher JI; Trahair TN
    Br J Cancer; 2022 Feb; 126(3):482-491. PubMed ID: 34471258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue Sarcomas.
    Uckunkaya O; Nöllke P; Hallmen E; Becker C; Stegmaier S; Sparber-Sauer M; Vokuhl C; Koscielniak E; Hettmer S
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e265-e270. PubMed ID: 32576783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.